SELLAS Life Sciences Group, Inc.
SLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001390478
No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in SELLAS Life Sciences Group, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +3 vs. Q2 2023
- Shares held
- 2.77M
- −359.7K (−11.5%) vs. Q2 2023
- Total value
- $4.54M
- −$370.4K (−7.5%) vs. Q2 2023
- New holders
- 5
- 9 more added
- Sold out
- 2
- 6 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 193 | $1.08B |
| Q1 2026 | 160 | $228.4M |
| Q4 2025 | 112 | $133.7M |
| Q3 2025 | 94 | $53.1M |
| Q2 2025 | 79 | $58.7M |
| Q1 2025 | 45 | $15.5M |
| Q4 2024 | 31 | $6.47M |
| Q3 2024 | 33 | $6.77M |
| Q2 2024 | 30 | $4.86M |
| Q1 2024 | 30 | $7.82M |
| Q4 2023 | 31 | $3.74M |
| Q3 2023 | 28 | $4.54M |
| Q2 2023 | 25 | $4.91M |
| Q1 2023 | 22 | $4.28M |
| Q4 2022 | 29 | $4.46M |
| Q3 2022 | 28 | $4.42M |
| Q2 2022 | 26 | $6.64M |
| Q1 2022 | 26 | $11.3M |
| Q4 2021 | 27 | $10.1M |
| Q3 2021 | 30 | $17.1M |
| Q2 2021 | 29 | $21.3M |
| Q1 2021 | 31 | $13.3M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding SELLAS Life Sciences Group, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,036,906 | $1.70M | 0.00% | +90,198+9.5% | Added |
| Alyeska Investment Group, L.P. | 640,011 | $1.05M | 0.01% | −609,989−48.8% | Reduced |
| BlackRock Inc. | 280,596 | $460.2K | 0.00% | −2,772−1.0% | Reduced |
| Geode Capital Management, LLC | 235,603 | $386.5K | 0.00% | +47,537+25.3% | Added |
| Equitable Holdings, Inc. | 135,000 | $221.4K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 97,129 | $159.3K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 70,446 | $115.5K | 0.00% | +54,984+355.6% | Added |
| Northern Trust Corp | 39,360 | $64.5K | 0.00% | 00.0% | Unchanged |
| Opus Capital Group, LLC | 34,500 | $57.0K | 0.01% | +3,500+11.3% | Added |
| XTX Topco Ltd | 32,982 | $54.1K | 0.01% | +32,982 | New |
| Prosperity Financial Group, Inc. | 24,800 | $40.7K | 0.03% | −5,000−16.8% | Reduced |
| Bank of New York Mellon Corp | 20,414 | $33.5K | 0.00% | −329−1.6% | Reduced |
| Virtu Financial LLC | 18,962 | $31.0K | 0.00% | +18,962 | New |
| Wells Fargo & Company | 16,317 | $26.8K | 0.00% | +30.0% | Added |
| Charles Schwab Investment Management Inc | 16,238 | $26.6K | 0.00% | 00.0% | Unchanged |
| Independent Financial Group, LLC | 15,650 | $25.7K | 0.00% | +3,000+23.7% | Added |
| Commonwealth Equity Services, LLC | 12,414 | $20.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 11,032 | $18.1K | 0.00% | +11,032 | New |
| Nemes Rush Group LLC | 10,000 | $16.4K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,014 | $14.8K | 0.00% | +1,971+28.0% | Added |
| JPMorgan Chase & Co | 4,034 | $6.62K | 0.00% | +2,034+101.7% | Added |
| Advisor Group Holdings, Inc. | 3,320 | $5.44K | 0.00% | +1,660+100.0% | Added |
| Morgan Stanley | 2,420 | $3.97K | 0.00% | −6,000−71.3% | Reduced |
| Allworth Financial LP | 150 | $246 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 26 | $43 | 0.00% | +26 | New |
| Parkside Financial Bank & Trust | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 2 | $3 | 0.00% | +2 | New |
| Royal Bank of Canada | 200 | $0 | 0.00% | −191−48.8% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −3,162−100.0% | Sold out |
| NewSquare Capital LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |